Abstract:Tau accumulation is a prominent feature in a variety of neurodegenerative disorders and remarkable effort has been expended working out the biochemistry and cell biology of this cytoplasmic protein. Tau's wayward properties may derive from germline mutations in the case of frontotemporal lobar degeneration (FTLD-MAPT) but may also be prompted by less understood cues—perhaps environmental or from molecular damage as a consequence of chronological aging—in the case of idiopathic tauopathies. Tau properties are undoubtedly affected by its covalent structure and in this respect tau protein is not only subject to changes in length produced by alternative splicing and endoproteolysis, but different types of posttranslational modifications that affect different amino acid residues. Another layer of complexity concerns alternate conformations—"conformers"—of the same covalent structures; in vivo conformers can encompass soluble oligomeric species, ramified fibrillar structures evident by light and electron microscopy and other forms of the protein that have undergone liquid-liquid phase separation to make demixed liquid droplets. Biological concepts based upon conformers have been charted previously for templated replication mechanisms for prion proteins built of the PrP polypeptide; these are now providing useful explanations to feature tau pathobiology, including how this protein accumulates within cells and how it can exhibit predictable patterns of spread across different neuroanatomical regions of an affected brain. In sum, the documented, intrinsic heterogeneity of tau forms and conformers now begins to speak to a fundamental basis for diversity in clinical presentation of tauopathy sub-types. In terms of interventions, emphasis upon subclinical events may be worthwhile, noting that irrevocable cell loss and ramified protein assemblies feature at end-stage tauopathy, whereas earlier events may offer better opportunities for diverting pathogenic processes. Nonetheless, the complexity of tau sub-types, which may be present even within intermediate disease stages, likely mitigates against one-size-fits-all therapeutic strategies and may require a suite of interventions. We consider the extent to which animal models of tauopathy can be reasonably enrolled in the campaign to produce such interventions and to slow the otherwise inexorable march of disease progression.

Local structural preferences in shaping tau amyloid polymorphism

Reconstitution of the Alzheimer’s Disease Tau Core Structure from Recombinant Tau297–391 Yields Variable Quaternary Structures as Seen by Negative Stain and Cryo-EM

Residual structure in the repeat domain of tau: echoes of microtubule binding and paired helical filament formation

Molecular Polymorphism of tau aggregates in Pick's disease

Functional classification of tauopathy strains reveals the role of protofilament core residues.

Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.

Cellular Biology of Tau Diversity and Pathogenic Conformers

Molecular rules governing the structural polymorphism of amyloid fibrils in neurodegenerative diseases

Structural mapping techniques distinguish the surfaces of fibrillar 1N3R and 1N4R human tau

A Two-Component Adhesive: Tau Fibrils Arise from a Combination of a Well-Defined Motif and Conformationally Flexible Interactions.

Interaction of full-length Tau with negatively charged lipid membranes leads to polymorphic aggregates

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

Emerging Trends in Cryo-EM-based Structural Studies of Neuropathological Amyloids

Polymorphism in Alzheimer Aβ Amyloid Organization: Insight into Aβ Aggregation

Structure-based classification of tauopathies

How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?

Structural Diversity of Dimers of the Alzheimer Amyloid-Beta(25-35) Peptide and Polymorphism of the Resulting Fibrils.

Polymerization of recombinant tau core fragments in vitro and seeding studies in cultured cells

MAPT mutations associated with familial tauopathies lead to formation of conformationally distinct oligomers that have cross‐seeding ability

Tau deposition patterns are associated with functional connectivity in primary tauopathies

Evaluating Triggers and Enhancers of Tau Fibrillization